Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06301542 · ClinicalTrials.gov registry record
Multimodal, Task-Aware Movement Assessment and Control Using Functional Electrical Stimulation
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 10
- Enrollment target
NCT06301542: Completed study, sponsored by Brigham and Women's Hospital.
NCT06301542 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06301542 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The study aims to investigate the relationship between post-stroke adults' movement patterns and disability levels. Utilizing the functional electrical stimulation (FES) system for individualized dorsiflexor and plantar flexor assistance during gait cycles. The investigators will analyze the cycles with and without the FES system. Initially, the context-aware motion assessment and neuroprosthetic control in a clinic will transition to in-home settings as the study progresses, broadening its application for safe and effective use at home.
Primary Outcome
Control functional electrical stimulation applied to paretic limb muscles of patients with post-stroke hemiparesis. Based on walking-related activities, the resulting controller will stimulate the target muscle groups with properties and amplitude.
Interventions
- DEVICE Functional electrical stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2024-05-31 |
What the finished NCT06301542 record still lists
NCT06301542 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Functional electrical stimulation is the first listed.
NCT06301542 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06301542 about?
NCT06301542 is a clinical study titled "Multimodal, Task-Aware Movement Assessment and Control Using Functional Electrical Stimulation". The study aims to investigate the relationship between post-stroke adults' movement patterns and disability levels. Utilizing the functional electrical stimulation (FES) system for individualized dorsiflexor and plantar flexor assistance during gait cycles. The investigators will analyze the cycles ...
What is the current status of trial NCT06301542?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2024-02-07. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT06301542?
The interventions under investigation include: Functional electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT06301542?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI